Clinical Trial Update: Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia [Phase 4]

View source ↗

Summary

This entry describes a Phase 4 clinical trial comparing Linezolid alone versus Linezolid plus a carbapenem for MRSA-related ventilator-associated pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection
• Ventilator-associated Pneumonia

Drugs mentioned

• Carbapenem (carbapenem)
• Linezolid (Linezolid)

Snippet

Sponsor: Ruijin Hospital | Conditions: Methicillin-resistant Staphylococcus Aureus, Pneumonia, Ventilator-Associated | Phase 4 | Status: UNKNOWN